semaglutide

New Delhi, March 31 Novo Nordisk India announced on Tuesday reductions in the prices of Ozempic and Wegovy in India, days after the launch of generic versions of semaglutide injections for patients with type 2 diabetes and obesity.Indian pharmaceutical companies recently announced the launch...

New Delhi, March 21 Pharmaceutical companies Torrent Pharmaceuticals, Alkem Laboratories, and USV Ltd. launched Semaglutide-based generic diabetes treatment medication in the country on Saturday.Torrent Pharma launched its Semaglutide brands, Sembolic and Semalix, in both oral and injectable...

New Delhi, March 21 Indian pharmaceutical companies Sun Pharma, Dr Reddy's, and Glenmark announced on Saturday the launch of their generic versions of semaglutide injection, used for diabetes and weight management, following the expiration of patents on products like Ozempic and Wegovy in India...

New Delhi, March 20 Eris Lifesciences launched a generic version of Semaglutide under the brand name 'Sundae' in the country on Friday, capitalizing on the expiration of patents for molecules similar to Ozempic and Wegovy in India.The company stated that it is introducing the diabetes and...

New Delhi, February 17 The apex drug regulator, CDSCO, has approved three drugs – Orlistat, Tirzepatide, and Semaglutide – for weight loss treatment in the country, which can be sold in retail with a doctor's prescription, Minister of State for Health, Anupriya Patel, said on Tuesday.All drugs...

New Delhi, February 27 Drug maker Abbott announced on Friday that it has partnered with Novo Nordisk India to commercialize Extensior, a second brand of Ozempic, for the treatment of type 2 diabetes in the country.The partnership leverages Novo Nordisk's scientific leadership in GLP-1s and...

New Delhi, February 24 Eris Lifesciences announced on Tuesday that it has partnered with Natco Pharma for the commercialization of semaglutide in India.Semaglutide, a GLP-1 receptor agonist, has emerged globally as a transformative therapy for the management of Type 2 diabetes and chronic...

New Delhi, February 11 OneSource Speciality Pharma announced on Wednesday that, along with Hikma, it has received approval from the Saudi Food and Drug Authority for a generic version of the diabetes and weight reduction medication Ozempic.The company has partnered with Hikma Pharmaceuticals...